Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 5, 2006
- Accepted after revision November 6, 2006
- Published online February 11, 2010.
Article Versions
- Latest version (December 24, 2009 - 22:48).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © American Society of Neuroradiology
Author Information
- S.K. Mukherjia
- aFrom the Departments of Radiology, Otolaryngology Head Neck Surgery, Radiation Oncology, and Periodontics and Oral Medicine, University of Michigan Health System, Ann Arbor, Michigan.
- Please address correspondence to Suresh K. Mukherji, MD, Department of Radiology, B2 A209–5030, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5030; e-mail: mukherji{at}umich.edu
Altmetrics
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials
- Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH
- Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy
- An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
- Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
- Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
- Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment